Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares, rose in value, with the stock price down by -0.04% to the previous day’s close as strong demand from buyers drove the stock to $0.75.
Actively observing the price movement in the recent trading, the stock is buoying the session at $0.75. Referring to stock’s 52-week performance, its high was $2.45, and the low was $0.28. On the whole, LXRX has fluctuated by 30.74% over the past month.
With the market capitalization of Lexicon Pharmaceuticals Inc currently standing at about $270.64 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
The stock’s technical analysis shows that the price of LXRX currently trading nearly 8.07% and 15.64% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 60.63, while the 7-day volatility ratio is showing 4.67% which for the 30-day chart, stands at 4.65%. Furthermore, Lexicon Pharmaceuticals Inc (LXRX)’s beta value is 1.01, and its average true range (ATR) is 0.06.
A comparison of Lexicon Pharmaceuticals Inc (LXRX) with its peers suggests the former has fared considerably weaker in the market. LXRX showed an intraday change of -0.04% in today’s session so far, and over the past year, it shrunk by -59.06%%.
Data on historical trading for Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) indicates that the trading volumes over the past 3 months, they’ve averaged 13.29 million. According to company’s latest data on outstanding shares, there are 363.18 million shares outstanding.
Nearly 51.26% of Lexicon Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 26.54% of the company’s shares. The stock has risen by 0.91% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the LXRX stock heading into the next quarter.
